These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 17419248

  • 1. Significance of p53 expression in gastrointestinal stromal tumors.
    Yalcinkaya U, Yerci O, Koc EU.
    Hepatogastroenterology; 2007; 54(73):140-3. PubMed ID: 17419248
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
    Can B, Sökmensüer C.
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The relationship between MIB-1 proliferative activity and mitotic index in gastrointestinal stromal tumors.
    Filiz G, Yalçinkaya O, Gürel S, Yerci O, Memik F.
    Hepatogastroenterology; 2007 Mar; 54(74):438-41. PubMed ID: 17523292
    [Abstract] [Full Text] [Related]

  • 8. High nuclear grade, frequent mitotic activity, cyclin D1 and p53 overexpression are associated with stromal invasion in mammary intracystic papillary carcinoma.
    Zhang C, Zhang P, Hao J, Quddus MR, Steinhoff MM, Sung CJ.
    Breast J; 2005 Mar; 11(1):2-8. PubMed ID: 15647071
    [Abstract] [Full Text] [Related]

  • 9. P53 and MIB-1 expression in gastrointestinal stromal tumor (GIST) of the stomach.
    Hata Y, Ishigami S, Natsugoe S, Nakajo A, Okumura H, Miyazono F, Matsumoto M, Hokita S, Aikou T.
    Hepatogastroenterology; 2006 Mar; 53(70):613-5. PubMed ID: 16995473
    [Abstract] [Full Text] [Related]

  • 10. Prognostic analysis of rectal stromal tumors by reference of National Institutes of Health risk categories and immunohistochemical studies.
    Tsai MC, Lin JW, Lin SE, Chen HH, Lee CM, Hu TH.
    Dis Colon Rectum; 2008 Oct; 51(10):1535-43. PubMed ID: 18633679
    [Abstract] [Full Text] [Related]

  • 11. [Risk factors for malignant evolution of gastrointestinal stromal tumors].
    Andrei S, Andrei A, Tonea A, Andronesi D, Becheanu G, Dumbravă M, Pechianu C, Herlea V, Popescu I.
    Chirurgia (Bucur); 2007 Oct; 102(6):641-50. PubMed ID: 18323226
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The significance of CD44 expression in gastrointestinal neuroendocrine tumors.
    Lai CH, Shan YS, Sy ED, Hsieh YH, Tsai HW, Lee JC, Lin PW.
    Hepatogastroenterology; 2005 Oct; 52(64):1071-6. PubMed ID: 16001632
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Coexpression of cyclooxygenase-2 and vascular endothelial growth factor in gastrointestinal stromal tumor: possible relations to pathological parameters and clinical behavior.
    Miao R, Liu N, Wang Y, Li L, Yu X, Jiang Y, Li J.
    Hepatogastroenterology; 2008 Oct; 55(88):2012-5. PubMed ID: 19260469
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biological behavior due to cell proliferation markers of gastrointestinal stromal tumors.
    Menéndez P, Padilla D, Cubo T, Villarejo P, Gambí D, Menéndez JM, Colina F, García M, Lora D, Martín J.
    Hepatogastroenterology; 2011 Oct; 58(105):76-80. PubMed ID: 21510290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.